Adamas nabs new U.S. patent covering Gocovri in Parkinson’s

Adamas nabs new U.S. patent covering Gocovri in Parkinson’s
The USPTO has issued a new patent to Adamas Pharmaceuticals (ADMS +1.4%) covering a method [Gocovri (amantadine)] of reducing "OFF" time and increasing "ON" time in Parkinson's disease ... read more
Source: Bing NewsPublished on 2020-05-13